What is APPCO Pharma?
APPCO Pharma is a New Jersey-based pharmaceutical company dedicated to developing and manufacturing high-quality, affordable generic medications. The company's facilities in Somerset and Piscataway are equipped to handle the entire drug development lifecycle, from initial conception through to commercialization, with a particular focus on solid oral dosage forms. APPCO's mission centers on providing therapeutic equivalents to brand-name pharmaceuticals, thereby increasing accessibility to essential medicines.
How much funding has APPCO Pharma raised?
APPCO Pharma has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in APPCO Pharma
PPP
Public-Private Partnership
What's next for APPCO Pharma?
The recent major strategic investment, contextualized within APPCO Pharma's overall enterprise-level funding, suggests a phase of significant scaling and market expansion. This capital infusion is likely to fuel further research and development, enhance manufacturing capabilities, and broaden the company's distribution network. APPCO Pharma appears poised to solidify its position as a key player in the generic drug market, potentially exploring new therapeutic areas or expanding its portfolio of affordable medications.
See full APPCO Pharma company page
